Vaccine Developer Moderna Could Slow COVID-19 Trials to Add At-Risk Minorities Vaccine Developer Moderna Could Slow COVID-19 Trials to Add At-Risk Minorities

Moderna has been asking sites that are conducting clinical trials of its experimental coronavirus vaccine to focus on enrolling at-risk minorities, even if that slows down the trial speed, the company said on Friday.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news